David J Porter

David J Porter

UNVERIFIED PROFILE

Are you David J Porter?   Register this Author

Register author
David J Porter

David J Porter

Publications by authors named "David J Porter"

Are you David J Porter?   Register this Author

10Publications

178Reads

15Profile Views

Do medical procedures in the arm increase the risk of lymphoedema after axillary surgery? A review.

ANZ J Surg 2014 Jul-Aug;84(7-8):510-4. Epub 2013 Nov 26.

Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.12474DOI Listing
September 2015

A pre-steady state and steady state kinetic analysis of the N-ribosyl hydrolase activity of hCD157.

Arch Biochem Biophys 2014 Dec 20;564:156-63. Epub 2014 Sep 20.

Platform Technology and Science, Molecular Discovery Research, Chemical Sciences, GlaxoSmithKline, 5 Moore Drive, 3.2094, Research Triangle Park, NC 27709, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.abb.2014.09.008DOI Listing
December 2014

The base exchange reaction of NAD+ glycohydrolase: identification of novel heterocyclic alternative substrates.

Arch Biochem Biophys 2008 Nov 22;479(2):114-20. Epub 2008 Sep 22.

Department of Biochemistry and Pharmacology, GlaxoSmithKline, 5 Moore Drive, 3.2114, Research Triangle Park, NC 27709, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000398610800442
Publisher Site
http://dx.doi.org/10.1016/j.abb.2008.09.005DOI Listing
November 2008

Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).

Bioorg Med Chem Lett 2008 Aug 24;18(15):4360-3. Epub 2008 Jun 24.

Department of Medicinal Chemistry, GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, NC 27709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2008.06.067DOI Listing
August 2008

Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamides.

Biochemistry 2004 Nov;43(45):14500-7

GlaxoSmithKline, Research Triangle Park, North Carolina 27709, and Upper Merion, Pennsylvania 19405, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi0488799DOI Listing
November 2004

HIV-1 protease: characterization of a catalytically competent enzyme-substrate intermediate.

Biochemistry 2002 Jan;41(4):1302-7

GlaxoSmithKline, V297.1C, 5 Moore Drive, Research Triangle Park, North Carolina 27709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi0116543DOI Listing
January 2002